TLIS
Talis Biomedical Corp. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website alisbio.com
- Employees(FY) 102
- ISIN US87424L2079
Performance
+2.33%
1W
-2.22%
1M
-3.3%
3M
+6.67%
6M
+18.12%
YTD
+30.66%
1Y
Profile
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also develops Talis One tests for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A and influenza B. The company was incorporated in 2013 and is headquartered in Redwood, California.
Technical Analysis of TLIS 2024-05-31
Overview:
In analyzing the technical indicators for TLIS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for informed deci...
Recent News & Updates
- 2022-02-28 19:00
- 2022-02-22 15:23
- 2022-01-31 21:05
- 2021-12-24 13:38
- 2021-12-21 01:00
- 2021-12-20 03:00
- 2021-12-13 22:16
- 2021-12-13 10:30
- 2021-12-12 23:15
- 2021-12-12 21:00
- 2021-12-09 20:00
- 2021-12-09 05:16
- 2021-12-08 06:30
- 2021-12-08 05:21
- 2021-12-08 02:51
- 2021-12-07 19:00
Talis Biomedical Announces Leadership Transition(Yahoo Finance)
- 2021-12-03 02:15
- 2021-12-02 21:00
- 2021-12-02 05:53
- 2021-12-02 04:00
- 2021-11-15 17:00
- 2021-11-15 03:05
- 2021-11-15 03:02
- 2021-11-11 23:00
- 2021-11-11 03:00
- 2021-11-07 19:00
- 2021-10-25 20:00
- 2021-10-12 00:36
- 2021-09-14 04:00
- 2021-09-14 01:32